Nebulized Versus Dry Powder Long-Acting Muscarinic Antagonist Bronchodilators in Patients With COPD and Suboptimal Peak Inspiratory Flow Rate

Background: Patients with chronic obstructive pulmonary disease (COPD) and suboptimal peak inspiratory flow rate (sPIFR) may not benefit optimally from dry powder inhalers (DPI) because of inadequate inspiratory flow. Nebulized bronchodilators may provide a better alternative. We compared bronchodil...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Chronic Obstr Pulm Dis
Autori principali: Mahler, Donald A., Ohar, Jill A., Barnes, Chris N., Moran, Edmund J., Pendyala, Srikanth, Crater, Gelnn D.
Natura: Artigo
Lingua:Inglês
Pubblicazione: COPD Foundation Inc 2019
Soggetti:
Original Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7006701/
https://ncbi.nlm.nih.gov/pubmed/31647854
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15326/jcopdf.6.4.2019.0137
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi